不良的病理特征影响切除术后小质的生存结果
Sari Khaleel1, Hong Truong2, Song Jiang1
1Urology Service, Memorial Sloan Kettering Cancer Center, New York, NY.
Urologic oncology
|July 9, 2023
概括
具有不良T3a特征的小质 (SRMs) 的结果比pT1a SRMs更糟糕. 这凸显了需要仔细的手术前规划和更密切的患者监测这些侵略性瘤的必要性.
科学领域:
- 泌尿器科 泌尿器科 泌尿器科 泌尿器科
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 4厘米以下的小质 (SRM) 通常在手术切除后具有良好的预后.
- 不良病理性T3a特征对SRM瘤结局的影响尚不清楚.
研究的目的:
- 为了比较手术切除的pT3a与pT1a小质 (SRM) 的临床结果.
主要方法:
- 对1837名因瘤小于4厘米而接受切除术的患者进行了回顾性审查.
- 使用统计分析对pT3a和pT1aSRM进行比较,包括对生存结果的Kaplan-Meier和Cox回归 (OS,CSS,RFS).
主要成果:
- 通过更高的脏得分,更大的瘤大小以及有关放射性特征,预测了pT3a升级.
- pT3a SRMs显示了较高的正边际率 (9.6%对4.1%),以及OS,RFS和CSS的不变结果更差.
- 多变量分析证实pT3a状态与更差的无复发生存率 (RFS) 有关.
结论:
- 小型脏质量的不良pT3a病理特征与较差的瘤结果有关.
- 术前规划和患者选择对于管理具有潜在T3a特征的SRM至关重要.
- 患有pT3aSRM的患者可能受益于更密切的监测和辅助治疗或临床试验的考虑.
更多相关视频
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
306
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
13.6K
相关概念视频
Acute Kidney Injury II: Pathophysiology
35
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
35
Cancer Survival Analysis
397
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
397
Kidney Transplant III: Nursing Management
41
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
41
Factors Affecting Renal Clearance: Renal Impairment
123
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
123
Kidney Transplant II: Surgical Procedure
36
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
36
Kaplan-Meier Approach
190
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
190
